1M. Kassem,R. Okazaki,S. A. Harris,T. C. Spelsberg,C. A. Conover,B. L. Riggs.Estrogen Effects on Insulin-Like Growth Factor Gene Expression in a Human Osteoblastic Cell Line with High Levels of Estrogen Receptor[J]. Calcified Tissue International . 1998 (1)
2Kawakami A,Eguchi k,Matsuoka N,et al.Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. Journal of Bone and Mineral Research . 1997
3Yasuda H,Shima N,Nakagawa N,et al.Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. The Journal of Endocrinology . 1998
4Tsuda E,Goto M,Mochizuki S,et al.Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis. Biochemical and Biophysical Research Communications . 1997
5Greenfield EM,Bi Y,Miyauchi A.Regulation of osteoclast activity. Life Sciences . 1999
6Suda T,Nakamura I,Jimi E,et al.Regulation of osteoclast function. Journal of Bone and Mineral Research . 1997
7Yasuda H,Shima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America . 1998
8Lacey DL,Timms E,Tan HL,et al.Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation. Cell . 1998
9Udagawa N,Takahashi N,Jimi E,et al.Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation FACTOR/RANKL but not macrophage colony-stimulating factor:receptor activator of NF-kappa B ligand. Bone . 1999
10Yamaguchi K,Kinosaki M,Goto M,et al.Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor. Journal of Biological Chemistry . 1998
